CAMBRIDGE, MA, According to MHT, Quanterix Corp. filed a federal document showing it has closed on $6 million of a new open-ended financing. Previous investors include ARCH Venture Partners, Bain Capital Ventures and Flagship Ventures.

Quanterix is a development stage company innovating ultra-sensitive detection systems for use in research and in-vitro diagnostics. Quanterix technology enables researchers and clinicians to gain completely new insights into disease by detecting previously hard to detect or undetectable biomarkers.